The abilities of the dihydropyridine calcium channel blocker nicardipine (Nic) to induce cytochrome P450 1 family enzymes (CYP1s) and to enhance the 3-methylcholanthrene (MC)-mediated induction of CYP1s and formation of MC-DNA adduct were examined in the human hepatoma cell line HepG2. The results from real time RT-PCR analysis demonstrated that Nic could induce CYP1 mRNAs and enhance the MC-mediated induction of the CYP1 mRNAs. The luciferase-reporter gene assay using the HepG2-A10 cell line, which has been previously established for the screening of aryl hydrocarbon receptor (AhR) activators, also indicated the augmentation of MC-mediated activation of AhR (induction of luciferase) by Nic, although Nic showed limited capacity for the activation of AhR. Furthermore, the results from the Western blot analysis of CYP1s, the enzyme activity assay, and the assay for MC-DNA adduct formation indicated that Nic could enhance the MC-mediated induction of CYP1s, especially CYP1A1. Furthermore, the intracellular accumulation level of [ C ytochrome P450 1 family enzymes (CYP1s), such as CYP1A1, CYP1A2, and CYP1B1, play an important role in the metabolic activation of carcinogenic polycyclic aromatic hydrocarbons (PAHs) and aromatic amines found in cigarette smoke and cooked foods.(1,2) For example, CYP1A1 and CYP1B1 are known to metabolize benzo[a]pyrene (B[a]P) and 3-methylcholanthrene (MC) to their ultimate carcinogenic forms, including their K(Bay)-region epoxides.(1,3) Moreover, carcinogenic susceptibilities of rodents toward PAHs and aromatic amines are closely correlated with the constitutive and ⁄ or carcinogen-induced levels of CYP1A1 ⁄ CYP1B1 and CYP1A2, respectively. (4)(5)(6)(7)(8)(9)